evidencegaps
Primary study · included by 1 review

Clinical factors associated with worse quality-of-life scores in United States thyroid cancer survivors.

Goswami 2019 · Goswami Sneha, Peipert Benjamin J, Mongelli Michael N, et al. · Surgery · 2019

Included by

Salivary and lacrimal disorders in patients treated with radioiodine for differentiated thyroid cancer.
Non-Cochrane · prognostic · 2026 · cited as Goswami 2019 · Supplementary Table S3 (included studies); Figs. 1-3
Outcome this study informsPooled effectEvidenceCertainty
Xerostomia (pooled prevalence)
Radioiodine (I131) therapy · within 2 months after RIT
Prevalence 0.60 [0.28, 0.85]3 studies · 1502 participantsGRADE not reported
Sialadenitis (pooled prevalence)
Radioiodine (I131) therapy · within 2 months after RIT
Prevalence 0.30 [0.12, 0.59]3 studies · 1563 participantsGRADE not reported

1 including review in total.